Study objective -The study investigated the joint effect of body mass index and systolic blood pressure on cardiovascular and total mortality. Design -This was a prospective cohort study. The main outcome measures were age adjusted mortality and relative risks estimated from survival models.
mortality in men and women aged 60-79 years at measurement a negative interaction between body mass index and systolic blood pressure was suggested in the first five years. Excluding the first five years, adjusted relative risks per 5 kglm2, were 1-05 (95% CI 0-96,1-15) in men and 1 11 (95% CI 1.04, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] in women in the older age group. There was an upturn in cardiovascular mortality at low levels of body mass index in both age groups of women, but not in men. Conclusions -Hypertension is an important risk factor for cardiovascular and all cause mortality even in the obese. Body mass index is generally a weak predictor of cardiovascular mortality in this population. It is a stronger risk factor of coronary death in men when measured at a younger age. Thin people with hypertension are not at particularly high risk ofdeath from coronary heart disease compared with their obese counterparts, except possibly in the first few years after measurement in the elderly. Being underweight is associated with increased risk of death from all cardiovascular causes in women, but not in men.
(J Epidemiol Community Health 1995; 49:265-270) In 1959 it was first shown that being overweight is associated with an increased risk of death from cardiovascular disease.' Weight is also correlated to blood pressure. One important question is whether weight is associated with cardiovascular mortality independent of blood pressure. It has been suggested that lean people with hypertension are at higher risk of cardiovascular mortality than their overweight/obese counterparts,2-5 and even that the positive association between blood pressure and cardiovascular mortality disappeared in the obese. 2 There is still controversy, however, about this question. The studies were mainly based on results in men. We present results from a large follow up study of both men and women ranging in age from 30-79 years in 1963 when they were examined in the city of Bergen, Norway. The end points studied are death from stroke, coronary heart disease, all cardiovascular causes, and all causes.
Methods
In 1963 all people aged 14 years or more were invited to a compulsory mass miniature x ray screening for pulmonary tuberculosis in the city ofBergen, Norway. A blood pressure survey was also carried out in connection with screening.89 Systolic and diastolic blood pressures were measured as well as weight and height. The present analyses are restricted to men and women aged 30-79 years at the time of examination, who were alive on 1 January 1964 and for whom measurements of weight and height are available. There were 21 145 men (74% of the invited population) and 30 330 women (86% ofthe invited population). The numbers in some of the tables may be slightly lower because some observations were missing for some of the participants.
Systolic and diastolic blood pressure were measured twice using a standard mercury sphygmomanometer and the lowest measurements were recorded. Cuffs that were 14 cm wide and 40 cm long were used throughout. , >zWo-men-
WVomen- years, and the last 12 years. Survival models for coronary heart disease mortality, with and without an interaction term between time interval and body mass index, were estimated. Introducing interaction terms into the models did not improve the fit significantly in either group. In the first five years there was no significant positive association between body mass index and coronary heart disease mortality (table 2) .
JOINT EFFECT OF BODY MASS INDEX AND SYSTOLIC BLOOD PRESSURE ON CARDIOVASCULAR AND TOTAL MORTALITY
Both total and cardiovascular mortality increased with increasing systolic blood pressure at all levels of body mass index in all groups (tables 3 and 4).
Stroke mortality varied very little with body mass index within the categories of systolic blood pressure. When adjusted for systolic blood pressure using Cox's survival model the associations turned out to be non-significant in all groups of men and women.
Coronary heart disease mortality was weakly but positively associated with body mass index at all levels of systolic blood pressure in men aged 30-59 years ( In men and women aged 60-79 years at baseline the thinnest group with the highest systolic blood pressure had the highest mortality from coronary heart disease (table 4) . Although weak, a negative interaction is suggested. Separate analyses for the first five years of follow up suggested a negative interaction in the first period (p=005 in men and p= 0-07 in women) but not in the rest of follow up. When the first five years were excluded the adjusted relative risk of death from coronary heart disease per 5 kg/m2 was only 1- ).
An upturn in total mortality at low levels of body mass index is seen in all categories of systolic blood pressure in both men and women of all ages. Discussion Systolic blood pressure was a positive predictor of stroke mortality at all levels of body mass index. The association between body mass index and stroke mortality was, however, weak in this study and disappeared when adjusting for systolic blood pressure. The association seems to be somewhat weaker than in another Norwegian study in which an increased risk at low levels of body mass index was also seen." The small number of observations in the category with the lowest body mass index in our study make the results inconclusive. A stronger effect of body mass index on stroke mortality was also found in a 26 year follow up of the Framingham heart study in women but not in men.'2 Previous results from the Whitehall study'3 showed that the relationship between body mass index and stroke mortality was stronger in non-smokers than in smokers and ex-smokers, and stronger when examined at younger ages. In 1963 the percentage of the Norwegian population that smoked regularly varied from 5% in women aged 70-75 years to around 40% in women aged 30-35 years and from 40% in men aged 70-75 years to around 65% in men aged 30-35 years.'4 Thus failure to adjust for smoking may be part of the explanation ofthe weak association between obesity and stroke mortality in men and in younger women in Bergen. With respect to age at examination, there is no consistent pattern. In the female population in Bergen the greatest relative risk was found in the youngest group. In men the relative risks were almost the same in both age groups and the confidence intervals overlapped substantially.
Systolic blood pressure is a strong predictor of coronary heart disease mortality at all levels of body mass index in all age groups of both men and women. The positive relationship between systolic blood pressure and the risk of coronary heart disease mortality did not disappear in the obese. Thus the results from this study do not support the hypothesis that blood pressure does not predict coronary heart disease mortality in the obese as demonstrated in a study in California.2 The confidence intervals for the relative risks associated with systolic blood pressure among lean and obese people overlapped substantially in that study, however, and a test for interaction was not presented. Other studies of the joint effect of blood pressure and body mass index show varying results. The studies of Cambien et al,3
the Israeli ischemic heart disease study,4 and the Whitehall study5 showed a negative interaction, as in the California study, but obese hypertensive subjects were still at increased risk of cardiovascular death compared with obese patients with normal blood pressure. Data from the Honolulu heart programme6 and the British regional heart study,7 on the other hand, showed no interaction between blood pressure and body mass index in respect of the risk of cardiovascular disease. In the Bergen popu-lation there may be a weak negative interaction between systolic blood pressure and body mass index in the older age groups: the leanest group with the highest systolic blood pressure had the highest risk of death from coronary heart disease. The reason for the discrepancy between studies is unknown. But The varying length of follow up may also explain why the strength of the association between body mass index and cardiovascular mortality differs between studies. It has been postulated that the effect of overweight may be evident only after longer periods of follow up. We investigated this by dividing the follow up period into three. There was no significant interaction between time interval and body mass index in either age group. Furthermore, there was no significant association between coronary heart disease mortality and body mass index in the first five years in either group. In the younger age group, the lack of significant associations in the first five years may be due to the small number ofdeaths in the first period.
Our results indicate that the relative risks of coronary heart disease mortality associated with obesity are higher when measured at a younger age in men, while this was not apparent in women. This was also a finding in the Framingham study. ' Some populations are leaner than others. The range of body mass index may also vary between populations. If the heterogeneity in body mass index is small, there will be a weaker association with mortality than ifthere are more people at the extremes of the distribution. Also people with the same body mass index may have quite different body composition and thus have a different risk of coronary heart disease.
This study showed that lean women are at increased risk of death from cardiovascular disease independent of blood pressure. There was a parabolic association in women, but not in men. The reason for the different association in men and women is unknown. A possible explanation is that the higher oestrogen levels in obese compared with lean postmenopausal women protect against cardiovascular disease.
In this study there was a parabolic relationship between body mass index and total mortality at all levels of blood pressure. When the true association is U shaped, different cut off points for definition of fatness-leanness influence the relative risks of lean versus fat hypertensives.'9 In a 8-3 year follow up of the hypertension detection and follow-up program, cause specific mortality was analysed to explore the increased all cause mortality in lean hypertensives. 20 The findings indicated that excess alcohol intake and smoking were important factors that contributed to the excess risk.
Blood pressure measurements are subject to measurement error. Using a cuff that is too small would lead to overestimation of blood pressure in the obese. The size of the cuff used in this study was sufficiently large to fit the fattest arms.
In this study hypertension was an important risk factor for cardiovascular mortality independent of body mass index. This may have important implications for blood pressure treatment in obese and lean people. Furthermore, lean hypertensives were not at particularly high risk of death from coronary heart disease compared with obese hypertensives, except possibly in the first few years after measurements in the elderly. The theory that weight reduction to lower blood pressure is not appropriate seems not to be justified. The finding of an upturn in cardiovascular mortality at low levels of body mass index in women, but not in men, warrants further investigation.
